Abstract
New vaccines designed to prevent human papillomavirus (HPV) infection have the potential to reduce the incidence of serious illness and death worldwide among women, substantially reduce the emotional suffering associated with abnormal Papanicolaou (Pap) test results and the diagnosis of cervical cancer, and save significant health care dollars. However, these benefits may not be fully realized until the vaccine is accepted by patients, parents, and health care practitioners. Furthermore, there may be unique issues related to the acceptance of a vaccine designed to prevent a sexually transmitted infection that is poorly understood by many women. Among the acceptance issues are: individual comfort with a sexually transmitted infection (STI) vaccine; parental comfort with vaccination of their preadolescent/early adolescent daughters; physician comfort with recommending a human papillomavirus vaccine to women and parents of preadolescents; and physician communication skills related to talking with women and parents about the vaccine. Potentially difficult as it might be to implement a vaccination program, vaccination and prevention of HPV-associated disease are still infinitely preferable to observation and treatment. This article will review some of the potential barriers to HPV Vaccine acceptance, with a particular focus on factors relevant to female patients, parents, and health care providers.
| Original language | English |
|---|---|
| Journal | Current Opinion in Obstetrics and Gynecology |
| Volume | 18 |
| Issue number | SUPPL. 1 |
| DOIs | |
| State | Published - Feb 2006 |
Fingerprint
Keywords
- Cervical cancer
- Genital warts
- Human papillomavirus (HPV)
- Vaccines
ASJC Scopus subject areas
- Obstetrics and Gynecology
Cite this
Understanding and overcoming barriers to human papillomavirus vaccine acceptance. / Zimet, Gregory.
In: Current Opinion in Obstetrics and Gynecology, Vol. 18, No. SUPPL. 1, 02.2006.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Understanding and overcoming barriers to human papillomavirus vaccine acceptance
AU - Zimet, Gregory
PY - 2006/2
Y1 - 2006/2
N2 - New vaccines designed to prevent human papillomavirus (HPV) infection have the potential to reduce the incidence of serious illness and death worldwide among women, substantially reduce the emotional suffering associated with abnormal Papanicolaou (Pap) test results and the diagnosis of cervical cancer, and save significant health care dollars. However, these benefits may not be fully realized until the vaccine is accepted by patients, parents, and health care practitioners. Furthermore, there may be unique issues related to the acceptance of a vaccine designed to prevent a sexually transmitted infection that is poorly understood by many women. Among the acceptance issues are: individual comfort with a sexually transmitted infection (STI) vaccine; parental comfort with vaccination of their preadolescent/early adolescent daughters; physician comfort with recommending a human papillomavirus vaccine to women and parents of preadolescents; and physician communication skills related to talking with women and parents about the vaccine. Potentially difficult as it might be to implement a vaccination program, vaccination and prevention of HPV-associated disease are still infinitely preferable to observation and treatment. This article will review some of the potential barriers to HPV Vaccine acceptance, with a particular focus on factors relevant to female patients, parents, and health care providers.
AB - New vaccines designed to prevent human papillomavirus (HPV) infection have the potential to reduce the incidence of serious illness and death worldwide among women, substantially reduce the emotional suffering associated with abnormal Papanicolaou (Pap) test results and the diagnosis of cervical cancer, and save significant health care dollars. However, these benefits may not be fully realized until the vaccine is accepted by patients, parents, and health care practitioners. Furthermore, there may be unique issues related to the acceptance of a vaccine designed to prevent a sexually transmitted infection that is poorly understood by many women. Among the acceptance issues are: individual comfort with a sexually transmitted infection (STI) vaccine; parental comfort with vaccination of their preadolescent/early adolescent daughters; physician comfort with recommending a human papillomavirus vaccine to women and parents of preadolescents; and physician communication skills related to talking with women and parents about the vaccine. Potentially difficult as it might be to implement a vaccination program, vaccination and prevention of HPV-associated disease are still infinitely preferable to observation and treatment. This article will review some of the potential barriers to HPV Vaccine acceptance, with a particular focus on factors relevant to female patients, parents, and health care providers.
KW - Cervical cancer
KW - Genital warts
KW - Human papillomavirus (HPV)
KW - Vaccines
UR - http://www.scopus.com/inward/record.url?scp=33746426005&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746426005&partnerID=8YFLogxK
U2 - 10.1097/01.gco.0000216317.10690.8f
DO - 10.1097/01.gco.0000216317.10690.8f
M3 - Article
C2 - 16520681
AN - SCOPUS:33746426005
VL - 18
JO - Current Opinion in Obstetrics and Gynecology
JF - Current Opinion in Obstetrics and Gynecology
SN - 1040-872X
IS - SUPPL. 1
ER -